Expression of insulin-like growth factor receptor, IGF-1, and IGF-2 in primary and metastatic osteosarcoma

Journal of Surgical Oncology

Volumn 69, Issue 1, 1998, Pages 21-27

  Burrow, Sarah ^a   Andrulis, Irene L ^a   Pollak, Michael ^b   Bell, Robert S ^a  

^a MOUNT SINAI HOSPITAL   (Canada)

^b MCGILL UNIVERSITY   (Canada)

Author keywords

Bone neoplasms; Insulin like growth factor; Insulin like growth factor receptor; Osteosarcoma; Sarcoma

Indexed keywords

SOMATOMEDIN C RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE CANCER; CELL LINE; CELL PROLIFERATION; CLINICAL ARTICLE; DISEASE ASSOCIATION; GENE EXPRESSION; HUMAN; HUMAN TISSUE; METASTASIS; NONHUMAN; OSTEOSARCOMA; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; TUMOR DIAGNOSIS;

BONE NEOPLASMS; HUMANS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; OSTEOSARCOMA; POLYMERASE CHAIN REACTION; RECEPTOR, IGF TYPE 1; RECEPTOR, IGF TYPE 2;

EID: 0031704545     PISSN: 00224790     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9098(199809)69:1<21::AID-JSO5>3.0.CO;2-M     Document Type: Article

References (40)

1. Bramwell VHC: The role of chemotherapy in osteogenic sarcoma. Crit Rev Oncol Hematol 1995;20:61-85.
2. Baserga R: The insulin-like growth factor I receptor: A key to tumor growth? Cancer Res 1995;55:249-252.
3. LeRoith D, Baserga R, Helman L, et al.: Insulin-like growth factors and cancer. Ann Intern Med 1995;122:54-59.
4. Macaulay VM: Insulin-like growth factors and cancer. Br J Cancer 1992;65:311-320.
5. Westley BR: Insulin-like growth factors: The unrecognized oncogenes. Br J Cancer 1995;72:1065-1066.
6. Daughaday WH, Rotwein P: Insulin-like growth factors I and II. Peptide, messenger ribonucleic acid and gene structures, serum, and tissue concentrations. Endocr Rev 1989;10:68-91.
7. Froesch ER, Schmid C, Schwander J, et al.: Actions of insulin-like growth factors. Annu Rev Physiol 1985;47:443-467.
8. Gammeltoft S, Christiansen J, Nielsen FC, et al.: Insulin growth factor II: Complexity of biosynthesis and receptor binding, molecular biology and physiology of insulin and insulin-like growth factors. Adv Exp Biol 1991;293:31-44.
9. Rechler MM, Nissley SP: The nature and regulation of the receptor for insulin-like growth factors. Annu Rev Physiol 1985;47: 425-442.
10. El-Badry OM, Minniti C, Kohn EC, et al.: Insulin-like growth factor II acts as an autocrine growth and motility in human rhabdomyosarcoma tumors. Cell Growth Differ 1990;1:325-331.
11. Hishinuma A, Yamanaka T, Kasal K, et al.: Growth regulation of the human papillary thyroid cancer cell line by protein tyrosine kinase and cAMP-dependent protein kinase. Endocr J 1994;41: 399-407.
12. Hwang C, Fang K, Li L, et al.: Insulin-like growth factor-I is an autocrine regulator for the brain metastatic variant of a human non-small cell lung cell line. Cancer Lett 1995;94:157-163.
13. Kleinman D, Karas M, Roberts CT, et al.: Modulation of insulin-like growth factor I (IGF-1) receptors and membrane-associated IGF-binding proteins in endometrial cancer cells by estradiol. Endocrinology 1995;136:2531-2537.
14. Pollak MN, Polychranos C, Richard M: IGF1: A potent mitogen for osteosarcoma. J Natl Cancer Inst 1990;82:219-224.
15. Tricoli JV, Rall LB, Karakousis CP, et al.: Enhanced levels of IGF mRNA in human colon carcinomas and liposarcomas. Cancer Res 1986;46:6169-6173.
16. Mathews LS, Norstedt G, Palmiter RD: Regulation of insulin-like growth factor gene by growth hormone. Proc Natl Acad Sci USA 1986;83:9343.
17. Sussenbach JS: The gene structure of the insulin-like growth factor. Prog Growth Factor Res 1989;1:33.
18. Rotwein P: Two insulin like growth factor I messenger RNAs expressed in liver. Proc Natl Acad Sci USA 1986;83:77.
19. Pietrzkowski Z, Sell C, Lammers R, et al.: Roles of insulin-like growth factor (IGF-1) and the IGF-1 receptor in epidermal growth factor stimulated growth of 3T3 cells. Mol Cell Biol 1992;12: 3883-3889.
20. DeAngelis T, Ferber A, Baserga R: Insulin-like growth factor I receptor is required for the mitogenic and transforming activities of the platelet-derived growth factor receptor. J Cell Physiol 1995; 164:214-221.
21. Morrione A, DeAngelis T, Baserga R: Failure of the bovine papillomavirus to transform mouse embryo fibroblasts with a targeted disruption of the insulin-like growth factor I receptor genes. J Virol 1995;69:5300-5303.
22. Valentis B, Porcu P, Quinn K, et al.: The role of the insulin-like growth factor I receptor in the transformation by simian virus 40 T antigen. Oncogene 1994;9:825-831.
23. Burgaud J, Resnicoff M, Baserga R: Mutant IGF-1 receptors as dominant negatives for growth and transformation. Biochem Biophys Res Commun 1995;214:475-481.
24. Nuenschwander S, Roberts CT, LeRoith D: Growth inhibition of MCF-7 breast cancer cells by stable expression of an insulin-like growth factor I receptor antisense ribonucleic acid. Endocrinology 1995;136:4298-1303.
25. Sekyi-Otu A, Bell RS, Ohashi C, et al.: Insulin-like growth factor I (IGF-1) receptors, IGF-1, and IGF-2 are expressed in primary human sarcomas. Cancer Res 1995;55:129-134.
26. Pollak M, Sem A, Richard M, et al.: Inhibition of metastatic behavior of murine osteosarcoma by hypophysectomy. J Natl Cancer Inst 1992;84:966-977.
27. Sekyi-Otu A, Bell RS, Andrulis I, et al.: Metastatic behavior of the RIF-1 murine fibrosarcoma: inhibited by hypophysectomy and partially restored by growth hormone replacement. J Natl Cancer Inst 1994;86:628-632.
28. Pollak MN: Somatostatin lowers metastatic rate in RIF murine sarcoma. (submitted).
29. Yang X, Beamer WG, Huynh H, et al.: Reduced growth of human breast cancer xenografts in hosts homozygous for the lit mutation. Cancer Res 1996;56:1509-1511.
30. Cullen KJ, Yee D, Sly WS, et al.: Insulin-like growth factor receptor expression and function in human breast cancer. Cancer Res 1990;50:48-53.
31. Reeve JG, Brinkman A, Hughes S, et al.: Expression of IGF and IGF-BP in human lung cancer cell lines. J Natl Cancer Inst 1992; 84:675-679.
32. Link MP, Goorin AM, Miser AW, et al.: The effect of adjuvant chemotherapy on relapse free survival in patients with osteosarcoma of the extremity. N Engl J Med 1986;314:1600-1606.
33. Link M, Goorin AM, Horowitz M, et al.: Adjuvant chemotherapy in osteosarcoma. Clin Orthop 1992;270:8-14.
34. Polednak AP: Human biology and epidemiology of childhood bone cancers: a review. Hum Biol 1985;57:1-26.
35. Price CHG: Osteogenic sarcoma: An analysis of the age and sex incidence. Br J Cancer 1955;9:558-5745.
36. Price CHG: Primary hone forming tumors and their relationship to skeletal growth. J Bone Joint Surg 1958;408:574-593.
37. Vassilopoulou-Sellin R, Wallis C, Samaan N: Hormonal evaluation of patients with osteosarcoma. J Surg Oncol 1985;28:209-213.
38. Pinski J, Schally AV, Groot K, et al.: Inhibition of growth of human osteosarcoma by antagonists of growth hormone-releasing hormone. J Natl Cancer Inst 1995;87:1787-1794.
39. Middleton J, Arnott N, Walsh S, Beresford J: The expression of mRNA for insulin-like growth factors and their receptor in giant cell tumors of human bone. Clin Orthop 1996;322:224-231.
40. Scotlandi K, Benini S, Sarti M, et al.: Insulin-like growth factor I receptor mediated circuit in Ewing's sarcoma/peripheral neuroectodermal tumor: A possible therapeutic target. Cancer Res 1996; 56:4570-4574.